Key points are not available for this paper at this time.
Background: This study demonstrates the difference between glucose management indicator (GMI) and glycated hemoglobin (HbA 1c ) according to sensor mean glucose and HbA 1c status using 2 continuous glucose monitoring (CGM) sensors in people with type 1 diabetes. Methods: A total of 275 subjects (117 Dexcom G6 G6 and 158 FreeStyle Libre 1 FL) with type 1 diabetes was included. The G6 and FL sensors were used, respectively, over 90 days to analyze 682 and 515 glycemic profiles that coincide with HbA 1c . Results: The mean HbA 1c was 6.6% in Dexcom G6 and 7.2% in FL profiles. In G6 profiles, GMI was significantly higher than HbA 1c irrespective of mean glucose (all P 0.5% improved from 60.1% to 30.9% when using the revised GMI equation in G6 profiles. In FL profile, the overall mean difference between GMI and HbA 1c was 0 ( P = .966). The GMI was significantly lower by 0.9% than HbA 1c of 9.0% to 9.9% and higher by 0.5% in HbA 1c of 5.0% to 5.9% (all P < .001). Conclusions: The GMI is overestimated in G6 users, particularly those with well-controlled diabetes, but the GMI and HbA 1c discordance improved with a revised equation from the observed data. The FL profile showed greater discordance for lower HbA 1c levels or higher HbA 1c levels.
Yoo et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: